Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Dzamko

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neuroscience|December 3, 2014
Inflammation is genetically implicated in Parkinson's diseaseN Dzamko, C L Geczy, G M Halliday
Scientific Reports|August 10, 2016
Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarkerG Perera, M Ranola, D B Rowe, et al.
Journal of Lipid Research|February 8, 2011
Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independentJ Jeppesen, P H Albers, A J Rose, et al.
Diabetologia|July 3, 2004
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metforminJ-M Ye, N Dzamko, M E Cleasby, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neuroscience|December 3, 2014
Inflammation is genetically implicated in Parkinson's diseaseN Dzamko, C L Geczy, G M Halliday
Scientific Reports|August 10, 2016
Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarkerG Perera, M Ranola, D B Rowe, et al.
Journal of Lipid Research|February 8, 2011
Contraction-induced skeletal muscle FAT/CD36 trafficking and FA uptake is AMPK independentJ Jeppesen, P H Albers, A J Rose, et al.
Diabetologia|July 3, 2004
Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metforminJ-M Ye, N Dzamko, M E Cleasby, et al.
Pageof 1